After having 17 melanoma spots removed, ‘Real Housewives of Beverly Hills’ alum Teddi Mellencamp was diagnosed with multiple ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

opening new avenues to improve the prognosis of patients with advanced cancer. These findings could lead to innovative ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

IGNORANCE about skin cancer — particularly melanoma ... dramatic changes have taken place in terms of treating advanced melanoma. This has resulted from two main discoveries where chemotherapy ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene 3 blocking antibody.

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.